| Financial Year |
March 31 2022 |
| Monetary Funds |
9,119,024.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
64,807,289.22 |
| Advances to Suppliers |
118,514,122.61 |
| Other Receivables |
6,984,003.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,490,675.52 |
| Total Current Assets |
231,915,115.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
375,585,174.57 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,548,977.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
429,134,151.90 |
| Total Assets |
661,049,267.51 |
| Short-Term Loans |
1,566,743,312.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
718,457,690.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,316,399.89 |
| Taxes Payable |
13,665,151.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
478,064,965.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
183,791,101.52 |
| Other Current Liabilities |
8,724,344.95 |
| Sub-Total of Current Liabilities |
3,041,947,700.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
71,756,300.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,686,220.05 |
| Total Liabilities |
3,114,633,920.75 |
| Paid-In Capital(Or Share Stock) |
300,150,000.00 |
| Capital Surplus |
557,220,307.33 |
| Surplus Reserve |
80,079,208.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,391,034,169.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,453,584,653.24 |
| Owner's Equity（Stockholder's Equity） |
-2,453,584,653.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
661,049,267.51 |
